Announcements Trials
Browse Landscape

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Stomach Neoplasms 15Colorectal Neoplasms 15Pancreatic Neoplasms 11Colonic Neoplasms 9Carcinoma, Hepatocellular 9Esophageal Neoplasms 6Rectal Neoplasms 5Colorectal Neoplasms, Hereditary Nonpolyposis 4Anus Neoplasms 4Neoplasms 3Gastrointestinal Stromal Tumors 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Squamous Intraepithelial Lesions 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Melanoma 2Endometrial Neoplasms 2Cholangiocarcinoma 2Bile Duct Neoplasms 2Acquired Immunodeficiency Syndrome 2Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Recurrence 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Papillomavirus Infections 1

Interventions

Gemcitabine 40Cisplatin 24Capecitabine 21Fluorouracil 19Oxaliplatin 17Leucovorin 14pembrolizumab 9Irinotecan 8Radiotherapy 7Erlotinib Hydrochloride 7durvalumab 6Sorafenib 4Photochemotherapy 4Magnetic Resonance Spectroscopy 4Carboplatin 4trametinib 3Trastuzumab 3Radiofrequency Ablation 3Long-Term Synaptic Depression 3Interleukin-12 Subunit p35 3Filgrastim 3Drug Therapy 3Dihematoporphyrin Ether 3Dexamethasone 3Cholangiopancreatography, Endoscopic Retrograde 3Chemotherapy, Adjuvant 3trifluridine tipiracil drug combination 2tivozanib 2tislelizumab 2spartalizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × Observation × Gastrointestinal × Clear all
NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Tempus AI

Active not recruiting
1,000 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT00767234 2016-07-11

Permission to Collect Blood Over Time for Research

Stanford University

Terminated
104 enrolled
GastrointestinalSarcoma

Anus Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡